Correlation Between Shenzhen Bioeasy and Shanghai Rightongene

Can any of the company-specific risk be diversified away by investing in both Shenzhen Bioeasy and Shanghai Rightongene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shenzhen Bioeasy and Shanghai Rightongene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shenzhen Bioeasy Biotechnology and Shanghai Rightongene Biotechnology, you can compare the effects of market volatilities on Shenzhen Bioeasy and Shanghai Rightongene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shenzhen Bioeasy with a short position of Shanghai Rightongene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shenzhen Bioeasy and Shanghai Rightongene.

Diversification Opportunities for Shenzhen Bioeasy and Shanghai Rightongene

0.65

Correlation Coefficient

Shenzhen Bioeasy  Shanghai Rightongene

Poor diversification

The 3 months correlation between Shenzhen and Shanghai is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Shenzhen Bioeasy Biotechnology and Shanghai Rightongene Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shanghai Rightongene and Shenzhen Bioeasy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shenzhen Bioeasy Biotechnology are associated (or correlated) with Shanghai Rightongene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shanghai Rightongene has no effect on the direction of Shenzhen Bioeasy i.e., Shenzhen Bioeasy and Shanghai Rightongene go up and down completely randomly.

Pair Corralation between Shenzhen Bioeasy and Shanghai Rightongene

Assuming the 90 days trading horizon Shenzhen Bioeasy Biotechnology is expected to under-perform the Shanghai Rightongene. In addition to that, Shenzhen Bioeasy is 1.13 times more volatile than Shanghai Rightongene Biotechnology. It trades about -0.16 of its total potential returns per unit of risk. Shanghai Rightongene Biotechnology is currently generating about -0.03 per unit of volatility. If you would invest  2,026  in Shanghai Rightongene Biotechnology on October 22, 2024 and sell it today you would lose (46.00) from holding Shanghai Rightongene Biotechnology or give up 2.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	95.24%
Values	Daily Returns

Shenzhen Bioeasy Biotechnology  vs.  Shanghai Rightongene Biotechno

Shenzhen Bioeasy Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shenzhen Bioeasy Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shenzhen Bioeasy is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shanghai Rightongene

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rightongene Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rightongene may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Shenzhen Bioeasy and Shanghai Rightongene

The main advantage of trading using opposite Shenzhen Bioeasy and Shanghai Rightongene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shenzhen Bioeasy position performs unexpectedly, Shanghai Rightongene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shanghai Rightongene will offset losses from the drop in Shanghai Rightongene's long position.

The idea behind Shenzhen Bioeasy Biotechnology and Shanghai Rightongene Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.